Oral Antidiabetics: Drug Classes, Actions, and Nursing Safety

Oral antidiabetic medications are a high-yield topic for nursing exams. This note organizes the four major classes by drug examples, mechanism of action, hypoglycemia risk, and the nursing safety priorities most likely to appear on the NCLEX.

Drug Identification

• Metformin — Metformin (biguanide); first-line agent for Type 2 diabetes.
• Sulfonylureas — Glipizide, Glyburide, Glimepiride; recognize the "gli-" prefix.
• GLP-1 agonists — Liraglutide, Semaglutide; recognize the "-tide" suffix.
• SGLT-2 inhibitors — Canagliflozin, Empagliflozin; recognize the "-flozin" suffix.

Mechanism of Action

• Metformin: Lowers glucose production by the liver.
• Sulfonylureas: Stimulate the pancreas to release insulin.
• GLP-1 agonists: Promote insulin release after meals and reduce appetite.
• SGLT-2 inhibitors: Remove excess glucose through the urine.

Key Differences at a Glance

• Metformin: Hypoglycemia rare. Biggest risk = lactic acidosis.
• Sulfonylureas: Hypoglycemia common. Biggest risk = severe hypoglycemia.
• GLP-1 agonists: Hypoglycemia rare. Biggest risk = pancreatitis.
• SGLT-2 inhibitors: Hypoglycemia rare. Biggest risks = DKA and UTIs.

Nursing Safety Rules

Metformin

• Hold before contrast dye procedures to reduce the risk of lactic acidosis.
• Avoid in patients with severe kidney failure.
• Administer with meals to reduce GI upset.

Sulfonylureas

• Give before meals to align insulin release with food intake.
• Monitor for signs of hypoglycemia: sweating, confusion, shakiness.
• Increased fall risk, especially in older adults.

GLP-1 Agonists

• Monitor for severe abdominal pain — a possible sign of pancreatitis.
• Commonly cause weight loss.

SGLT-2 Inhibitors

• Encourage adequate fluid intake to prevent dehydration.
• Monitor for urinary tract infections.
• DKA can occur even with normal blood glucose levels (euglycemic DKA).

Common Exam Traps

• Assuming metformin causes hypoglycemia (it rarely does).
• Forgetting to check kidney function before giving metformin or SGLT-2 inhibitors.
• Ignoring abdominal pain in a patient on a GLP-1 agonist.
• Missing DKA in SGLT-2 patients because glucose looks normal.
• Giving a sulfonylurea without food, leading to hypoglycemia.

Key Takeaways

• Metformin lowers hepatic glucose production, rarely causes hypoglycemia, and must be held before contrast dye.
• Sulfonylureas are the class most likely to cause hypoglycemia — always give with food.
• GLP-1 agonists promote weight loss but require monitoring for pancreatitis.
• SGLT-2 inhibitors can cause UTIs and euglycemic DKA; ensure adequate hydration.
• Always assess kidney function before initiating metformin or SGLT-2 inhibitors.